ketoconazole has been researched along with Moniliasis, Oral in 112 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 8.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 7.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 7.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "A father and son, both suffering from chronic mucocutaneous candidiasis, were successfully treated with oral ketoconazole, a water-soluble imidazole compound." | 7.66 | Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole. ( Anderson, R; Morrison, JG, 1981) |
| "Acute generalized exanthematous pustulosis is a rare disorder characterized by an acute onset of generalized, nonfollicular, pustular eruption associated with fever." | 5.36 | Childhood acute generalized exanthematous pustulosis induced by oral ketoconazole. ( Kadurina, M; Miteva, L; Schwartz, RA, 2010) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 5.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "To determine the efficacy and toxicity of two systemically active antifungal agents in the treatment of buccal and oesophageal candidiasis 111 HIV-infected patients with microscopically-confirmed candidiasis were randomized to receive either 200 mg itraconazole once a day or 200 mg ketoconazole twice a day for 28 days in a double blind study." | 5.07 | Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. ( Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE, 1991) |
| "In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)." | 5.06 | Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989) |
| "A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients." | 4.81 | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001) |
| "Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 4.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
| "A 77-y-old patient developed weakness of extremities, legs paralysis, dysarthria and tremor 1 h after ingestion of 200 mg ketoconazole for the first time in his life." | 3.72 | Ketoconazole-induced neurologic sequelae. ( Berkovitch, M; Bulkowstein, M; Mordish, Y; Sherman, E; Zimmerman, DR, 2003) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 3.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "We describe a patient with the acquired immunodeficiency syndrome who had persistent oral esophageal pseudomembranous candidiasis clinically refractory to nystatin, clotrimazole, and ketoconazole." | 3.68 | Treatment of refractory oral candidiasis with fluconazole. A case report. ( Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM, 1991) |
| "Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 3.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
| "A father and son, both suffering from chronic mucocutaneous candidiasis, were successfully treated with oral ketoconazole, a water-soluble imidazole compound." | 3.66 | Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole. ( Anderson, R; Morrison, JG, 1981) |
| "Denture stomatitis is a common and recurring problem of denture wearers." | 2.75 | Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. ( Khozeimeh, F; Noori, M; Savabi, O; Shahtalebi, MA, 2010) |
| "A retrospective review of 112 HIV/AIDS patients with lesions in the mouth, head, and neck seen at the oral and maxillofacial surgery units of two public hospitals in eastern Nigeria was carried out between 2000 and 2003." | 2.73 | Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. ( Chukwuneke, F; Oji, C, 2008) |
| "Twelve HIV-infected patients were assigned into a one-sequence, two-period pharmacokinetic interaction study." | 2.73 | Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients. ( Jaruratanasirikul, S; Mahatthanatrakul, W; Ridtitid, W; Sriwiriyajan, S, 2007) |
| " The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
| " Twenty-four subjects received oral fluconazole in a dosage of 3 mg/kg/day and 22 subjects received oral ketoconazole in a dosage of 7 mg/kg/day." | 2.67 | Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group. ( Hernández-Sampelayo, T, 1994) |
| " In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
| "Ketoconazole was administered in a 200 mg dose twice daily." | 2.66 | A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients. ( Malcom, LG; Vogler, WR; Winton, EF, 1987) |
| " The drug was administered orally in the dosage of 200 mg/m2 of body surface per day for two weeks to cancer patients with oral candidiasis." | 2.65 | Ketoconazole and candidiasis: a controlled study. ( Bartley, DL; Hughes, WT; Patterson, GG; Tufenkeji, H, 1983) |
| "Treatment of cancer is increasingly effective but is associated with short and long term side effects." | 2.44 | Interventions for treating oral candidiasis for patients with cancer receiving treatment. ( Clarkson, JE; Eden, OB; Worthington, HV, 2007) |
| "Treatment of cancer is increasingly effective but is associated with short and long-term side effects." | 2.42 | Interventions for treating oral candidiasis for patients with cancer receiving treatment. ( Clarkson, JE; Eden, OB; Worthington, HV, 2004) |
| " A newly recognized phenomenon known as the post-antifungal effect implies that antifungals, even at sub-therapeutic concentrations, may suppress the virulent attributes of yeasts, especially intra-orally where topical drug levels fluctuate dramatically during dosing intervals." | 2.41 | Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. ( Ellepola, AN; Samaranayake, LP, 2000) |
| "Treatment of cancer is increasingly effective but is associated with short and long-term side effects." | 2.41 | Interventions for treating oral candidiasis for patients with cancer receiving treatment. ( Clarkson, JE; Eden, OB; Worthington, HV, 2002) |
| " The topical agents are available in assorted dosage forms with varying degrees of efficacy and patient acceptability." | 2.39 | Treatment of oropharyngeal candidiasis in HIV-positive patients. ( Greenspan, D, 1994) |
| "Ketoconazole tablets were used with good success in previous years of the AIDS epidemics." | 2.39 | [Therapy of candidiasis and cryptococcosis in AIDS]. ( Just-Nübling, G, 1994) |
| "Oral candidiasis is an opportunistic disease caused by fungi of the Candida genus." | 1.62 | Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp. ( Araújo, RPC; Deegan, KR; Fonseca, MS; Machado, BAS; Meyer, R; Portela, RW; Sokolonski, AR; Umsza-Guez, MA, 2021) |
| "Oral candidiasis was detected in 20% of the patients." | 1.51 | Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions. ( Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K, 2019) |
| "Hydroxyurea therapy in sickle cell anemia patients maintains fungal species balance in oral cavity." | 1.39 | Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance. ( Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC, 2013) |
| "oral isolates from type 1 and type 2 diabetes when compared to matched controls." | 1.37 | Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. ( Back-Brito, GN; Balducci, I; Bremenkamp, RM; Brighenti, FL; Caris, AR; Jorge, AO; Koga-Ito, CY; Mota, AJ, 2011) |
| "Miconazole was the most popular choice of antifungal agent prescribed (59." | 1.36 | Use of antifungal agents for oral candidiasis: results of a national survey. ( Jornet-García, V; López-Jornet, P; Martínez-Beneyto, Y; Velandrino-Nicolás, A, 2010) |
| "Acute generalized exanthematous pustulosis is a rare disorder characterized by an acute onset of generalized, nonfollicular, pustular eruption associated with fever." | 1.36 | Childhood acute generalized exanthematous pustulosis induced by oral ketoconazole. ( Kadurina, M; Miteva, L; Schwartz, RA, 2010) |
| "Chronic mucocutaneous candidiasis is a immuno deficiency disorder primarily due to T cell dysfunction characterized by persistent candidal infection of mucous membrane, skin, scalp and nails." | 1.32 | Chronic mucocutaneous candidiasis: a case report. ( Bhowate, R; Dubey, A, 2004) |
| "isolated from the oral cavities of AIDS patients." | 1.30 | Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure. ( Burattini, MN; Colombo, AL; Costa, PR; Fischmann, O; Kallás, EG; Milan, EP, 1998) |
| " glabrata was less susceptible (4-8 mg/l) or resistant (> 8 mg/l) to fluconazole and resistant to itraconazole and ketoconazole High dosed intravenous fluconazole treatment with 400 to 600 mg daily failed in 11 patients with fluconazole resistant C." | 1.30 | [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. ( Hofmann, H; Metzger, S, 1997) |
| " Further, these results may have an important bearing on dosage regimens currently employed in treating oral candidosis." | 1.30 | Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. ( Ellepola, AN; Samaranayake, LP, 1998) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 1.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "Invasive fungal infections are becoming increasingly frequent among immunocompromised patients and especially among cancer patients." | 1.27 | Treatment of mycoses in cancer patients. ( Meunier-Carpentier, F, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (31.25) | 18.7374 |
| 1990's | 46 (41.07) | 18.2507 |
| 2000's | 21 (18.75) | 29.6817 |
| 2010's | 8 (7.14) | 24.3611 |
| 2020's | 2 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, FM | 1 |
| Staudigel, A | 1 |
| Salvenmoser, S | 1 |
| Tredup, A | 1 |
| Miltenberger, R | 1 |
| Herrmann, JV | 1 |
| Sokolonski, AR | 1 |
| Fonseca, MS | 1 |
| Machado, BAS | 1 |
| Deegan, KR | 1 |
| Araújo, RPC | 1 |
| Umsza-Guez, MA | 1 |
| Meyer, R | 1 |
| Portela, RW | 1 |
| Pakshir, K | 1 |
| Ghasemi, N | 1 |
| Zomorodian, K | 1 |
| Jowkar, F | 1 |
| Nouraei, H | 1 |
| Dastgheib, L | 1 |
| Ohta, K | 1 |
| Yoshimura, H | 1 |
| Tantivitayakul, P | 1 |
| Lapirattanakul, J | 1 |
| Kaypetch, R | 1 |
| Muadcheingka, T | 1 |
| Ellepola, AN | 6 |
| Jayathilake, JA | 1 |
| Sharma, PN | 1 |
| Khan, ZU | 1 |
| Nadagir, SD | 1 |
| Chunchanur, SK | 1 |
| Halesh, LH | 1 |
| Yasmeen, K | 1 |
| Chandrasekhar, MR | 1 |
| Patil, BS | 1 |
| Oji, C | 1 |
| Chukwuneke, F | 1 |
| Martínez-Beneyto, Y | 1 |
| López-Jornet, P | 1 |
| Velandrino-Nicolás, A | 1 |
| Jornet-García, V | 1 |
| Khozeimeh, F | 1 |
| Shahtalebi, MA | 1 |
| Noori, M | 1 |
| Savabi, O | 1 |
| Bremenkamp, RM | 1 |
| Caris, AR | 1 |
| Jorge, AO | 1 |
| Back-Brito, GN | 1 |
| Mota, AJ | 1 |
| Balducci, I | 1 |
| Brighenti, FL | 2 |
| Koga-Ito, CY | 2 |
| Miteva, L | 1 |
| Kadurina, M | 1 |
| Schwartz, RA | 1 |
| Salvia, AC | 1 |
| Figueiredo, MS | 1 |
| Braga, JA | 1 |
| Pereira, DF | 1 |
| Tacconelli, E | 2 |
| Bertagnolio, S | 1 |
| Posteraro, B | 2 |
| Tumbarello, M | 2 |
| Boccia, S | 1 |
| Fadda, G | 1 |
| Cauda, R | 2 |
| Bulkowstein, M | 1 |
| Mordish, Y | 1 |
| Zimmerman, DR | 1 |
| Sherman, E | 1 |
| Berkovitch, M | 1 |
| Clarkson, JE | 3 |
| Worthington, HV | 3 |
| Eden, OB | 3 |
| Bhowate, R | 1 |
| Dubey, A | 1 |
| Kuriyama, T | 1 |
| Williams, DW | 1 |
| Bagg, J | 1 |
| Coulter, WA | 1 |
| Ready, D | 1 |
| Lewis, MA | 2 |
| Sriwiriyajan, S | 1 |
| Mahatthanatrakul, W | 1 |
| Ridtitid, W | 1 |
| Jaruratanasirikul, S | 1 |
| Chen, FC | 1 |
| Lin, M | 1 |
| Kamalam, A | 1 |
| Thambiah, AS | 1 |
| Sheklakov, ND | 1 |
| Delektorskiĭ, VV | 1 |
| Stepanova, ZhV | 1 |
| Masiukova, SA | 1 |
| Schmitt, HJ | 1 |
| Gutjahr, P | 1 |
| Donnelly, JP | 1 |
| Starke, ID | 1 |
| Galton, DA | 1 |
| Catovsky, D | 1 |
| Goldman, JM | 1 |
| Darrell, JH | 1 |
| Graybill, JR | 1 |
| Herndon, JH | 1 |
| Kniker, WT | 1 |
| Levine, HB | 1 |
| Morrison, JG | 1 |
| Anderson, R | 1 |
| Meier, J | 1 |
| Jones, HE | 1 |
| Meunier-Carpentier, F | 1 |
| Hughes, WT | 1 |
| Bartley, DL | 1 |
| Patterson, GG | 1 |
| Tufenkeji, H | 1 |
| Saule, H | 1 |
| Collins, JR | 1 |
| Van Sickels, JE | 1 |
| Bennett, JE | 1 |
| Deutsch, PH | 1 |
| Quintiliani, R | 1 |
| Zakrzewska, JM | 1 |
| Aly, Z | 1 |
| Speight, PM | 1 |
| Just-Nübling, G | 2 |
| Johnson, EM | 1 |
| Warnock, DW | 1 |
| Luker, J | 1 |
| Porter, SR | 1 |
| Scully, C | 1 |
| Greenspan, D | 2 |
| Pérusse, R | 1 |
| Hernández-Sampelayo, T | 1 |
| van der Bijl, P | 1 |
| Arendorf, TM | 1 |
| Heinic, GS | 1 |
| Stevens, DA | 1 |
| MacPhail, LA | 1 |
| Dodd, CL | 1 |
| Stringari, S | 1 |
| Strull, WM | 1 |
| Hollander, H | 1 |
| St-Germain, G | 1 |
| Dion, C | 1 |
| Espinel-Ingroff, A | 1 |
| Ratelle, J | 1 |
| de Repentigny, L | 1 |
| Tebbe, B | 1 |
| Boyvat, A | 1 |
| Geilen, CC | 1 |
| Wölfer, LU | 1 |
| Seibold, M | 1 |
| Orfanos, CE | 1 |
| Silverman, S | 3 |
| Gallo, JW | 1 |
| McKnight, ML | 2 |
| Mayer, P | 2 |
| deSanz, S | 1 |
| Tan, MM | 1 |
| Caldarola, G | 1 |
| Morace, G | 1 |
| Ortona, L | 1 |
| Taylor, CB | 1 |
| Finlay, R | 1 |
| Richardson, C | 1 |
| Bunting, P | 1 |
| Welch, J | 1 |
| Nittayananta, W | 2 |
| Kumplanont, P | 1 |
| Srisintorn, S | 1 |
| Akkayanont, P | 1 |
| Chungpanich, S | 1 |
| Teanpaisan, R | 2 |
| Chareonwatanan, M | 1 |
| Nuntanaranont, T | 1 |
| Diz Dios, P | 1 |
| Vázquez García, E | 1 |
| Cartledge, JD | 3 |
| Midgley, J | 4 |
| Gazzard, BG | 4 |
| Ramirez-Amador, V | 1 |
| Tyler, M | 1 |
| Quivey, J | 1 |
| Ustianowski, AP | 1 |
| Leake, H | 1 |
| Evans, S | 1 |
| Petrou, M | 1 |
| Shanson, D | 1 |
| Metzger, S | 1 |
| Hofmann, H | 1 |
| Fortun Abete, J | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Samaranayake, LP | 6 |
| Nébavi, F | 1 |
| Arnavielhe, S | 1 |
| Le Guennec, R | 1 |
| Ménan, E | 1 |
| Kacou, A | 1 |
| Combe, P | 1 |
| Aoussi, E | 1 |
| Mallié, M | 1 |
| Koné, M | 1 |
| Bastide, JM | 1 |
| Milan, EP | 2 |
| Burattini, MN | 1 |
| Kallás, EG | 1 |
| Fischmann, O | 1 |
| Costa, PR | 1 |
| Colombo, AL | 2 |
| Zhang, H | 1 |
| Lu, Y | 1 |
| Liang, D | 1 |
| Chongsuvivatwong, V | 1 |
| Kantipong, P | 1 |
| Walsh, DS | 1 |
| Barr, D | 1 |
| Smart, T | 1 |
| Samaranayake, YH | 1 |
| Tsang, PC | 1 |
| Wong, KH | 1 |
| Yeung, KW | 1 |
| Patton, LL | 1 |
| Bonito, AJ | 1 |
| Shugars, DA | 1 |
| Anil, S | 1 |
| Cornejo, LS | 1 |
| López de Blanc, S | 1 |
| Femopase, F | 1 |
| Azcurra, A | 1 |
| Calamari, S | 1 |
| Battellino, LJ | 1 |
| Dorronsoro de Cattoni, ST | 1 |
| Sant'Ana, Pde L | 1 |
| Martinez, R | 1 |
| Queiroz-Telles, F | 1 |
| Ferreira, MS | 1 |
| Alcântara, AP | 1 |
| Carvalho, MT | 1 |
| Barchiesi, F | 1 |
| Giacometti, A | 1 |
| Arzeni, D | 1 |
| Branchesi, P | 1 |
| Crescenzi, G | 1 |
| Ancarani, F | 1 |
| Scalise, G | 1 |
| Gallagher, PJ | 1 |
| Bennett, DE | 1 |
| Henman, MC | 1 |
| Russell, RJ | 1 |
| Flint, SR | 1 |
| Shanley, DB | 1 |
| Coleman, DC | 1 |
| Fotos, PG | 1 |
| Vincent, SD | 1 |
| Hellstein, JW | 1 |
| Burton, DM | 1 |
| Seid, AB | 1 |
| Kearns, DB | 1 |
| Pransky, SM | 1 |
| Nyst, MJ | 1 |
| Perriens, JH | 1 |
| Kimputu, L | 1 |
| Lumbila, M | 1 |
| Nelson, AM | 1 |
| Piot, P | 1 |
| Samaranyake, LP | 1 |
| Lamey, PJ | 1 |
| Smith, DE | 1 |
| Allan, M | 1 |
| Connolly, GM | 1 |
| Schmidt-Westhausen, A | 1 |
| Schiller, RA | 1 |
| Pohle, HD | 1 |
| Reichart, PA | 1 |
| Gentschew, G | 1 |
| Meissner, K | 1 |
| Odewald, J | 1 |
| Staszewski, S | 1 |
| Helm, EB | 2 |
| Stille, W | 2 |
| Willocks, L | 1 |
| Leen, CL | 2 |
| Brettle, RP | 1 |
| Urquhart, D | 1 |
| Russell, TB | 1 |
| Milne, LJ | 1 |
| Lucatorto, FM | 1 |
| Franker, C | 1 |
| Hardy, WD | 1 |
| Chafey, S | 1 |
| Fox, R | 1 |
| Neal, KR | 1 |
| Ellis, ME | 1 |
| Mandal, BK | 1 |
| Kitchen, VS | 1 |
| Savage, M | 1 |
| Harris, JR | 1 |
| Blatchford, NR | 1 |
| Thorsen, S | 1 |
| Mathiesen, LR | 1 |
| Martin, MV | 1 |
| De Wit, S | 1 |
| Weerts, D | 1 |
| Goossens, H | 1 |
| Clumeck, N | 1 |
| Tejerina Lobo, JM | 1 |
| Bagan Sebastián, JV | 1 |
| Ramón Muñiz, J | 1 |
| Migliorati, C | 1 |
| Luangjarmekorn, L | 1 |
| Sererat, T | 1 |
| Taniguchi, K | 1 |
| Gallo, J | 1 |
| Boon, JM | 1 |
| Lafeber, HN | 1 |
| Mannetje, AH | 1 |
| van Olphen, AH | 1 |
| Smeets, HL | 1 |
| Toorman, J | 1 |
| van der Vlist, GJ | 1 |
| Markitziu, A | 1 |
| Katz, J | 1 |
| Pisanty, S | 1 |
| Feuillan, P | 1 |
| Poth, M | 1 |
| Reilly, W | 1 |
| Bright, G | 1 |
| Loriaux, DL | 1 |
| Chrousos, GP | 1 |
| Cade, JE | 1 |
| Lancaster, DM | 1 |
| Barsley, RE | 1 |
| Kitching, NH | 1 |
| Allen, CM | 1 |
| Rossie, KM | 1 |
| Haring, JI | 1 |
| Beck, FM | 1 |
| Rodu, B | 1 |
| Carpenter, JT | 1 |
| Jones, MR | 1 |
| Sukolin, GI | 1 |
| Riumin, DV | 1 |
| Narzullaeva, RI | 1 |
| Arushanova, SA | 1 |
| Balogh, G | 1 |
| Carter, GM | 1 |
| Kerr, MA | 1 |
| Shepherd, MG | 1 |
| Hansen, RM | 1 |
| Reinerio, N | 1 |
| Sohnle, PG | 1 |
| Abrams, RA | 1 |
| Ritch, PS | 1 |
| Libnoch, JA | 1 |
| Anderson, T | 1 |
| Vogler, WR | 1 |
| Malcom, LG | 1 |
| Winton, EF | 1 |
| Zelen, B | 1 |
| Rao, SP | 1 |
| Hammerschlag, MR | 1 |
| Walk, JA | 1 |
| Daugaard, K | 1 |
| Nielsen, H | 1 |
| Schiodt, M | 1 |
| Enzensberger, W | 1 |
| Hopp, G | 1 |
| Fischer, PA | 1 |
15 reviews available for ketoconazole and Moniliasis, Oral
| Article | Year |
|---|---|
Interventions for treating oral candidiasis for patients with cancer receiving treatment.
Topics: Antifungal Agents; Candidiasis, Oral; Clotrimazole; Humans; Ketoconazole; Neoplasms; Randomized Cont | 2004 |
Interventions for treating oral candidiasis for patients with cancer receiving treatment.
Topics: Antifungal Agents; Candidiasis, Oral; Clotrimazole; Humans; Ketoconazole; Neoplasms; Randomized Cont | 2007 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococc | 1994 |
Treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T- | 1994 |
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; | 1993 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug | 2000 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, | 2001 |
Interventions for treating oral candidiasis for patients with cancer receiving treatment.
Topics: Antifungal Agents; Candidiasis, Oral; Clotrimazole; Humans; Ketoconazole; Neoplasms; Randomized Cont | 2002 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen | 2000 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune T | 1991 |
Treatment of oral candidosis with itraconazole: a review.
Topics: Antifungal Agents; Candidiasis, Oral; Humans; Itraconazole; Ketoconazole | 1990 |
Ketoconazole therapy for acute pseudomembranous candidiasis: a case report.
Topics: Acute Disease; Candidiasis, Oral; Female; Humans; Ketoconazole; Middle Aged | 1988 |
19 trials available for ketoconazole and Moniliasis, Oral
| Article | Year |
|---|---|
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adolescent; Adult; Aged; AIDS-Related O | 2008 |
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis.
Topics: Administration, Buccal; Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Candidiasi | 2010 |
Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Area Unde | 2007 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Adolescent; Adult; Amphotericin B; Antineoplastic Agents; Candidiasis, Oral; Candidiasis, Vulvovagin | 1984 |
Ketoconazole and candidiasis: a controlled study.
Topics: Adolescent; Antifungal Agents; Candidiasis, Oral; Child; Clinical Trials as Topic; Double-Blind Meth | 1983 |
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconaz | 1995 |
Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Child; C | 1994 |
Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Doubl | 1995 |
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 1996 |
Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; H | 1997 |
Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1998 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Ca | 1998 |
Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Democratic Republic of the Congo; Fema | 1992 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; | 1991 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1989 |
Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study.
Topics: Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Humans; Immunosuppres | 1987 |
A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Candidiasis, Oral; Female; Humans; Immune T | 1987 |
78 other studies available for ketoconazole and Moniliasis, Oral
| Article | Year |
|---|---|
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Ora | 2007 |
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sen | 2021 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial T | 2019 |
Candida-Associated Cheilitis.
Topics: Aged; Anti-Infective Agents, Local; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cheiliti | 2020 |
Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
Topics: Antifungal Agents; Azoles; Candida; Candida glabrata; Candidiasis, Oral; DNA-Binding Proteins; Drug | 2019 |
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocan | 2016 |
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 2008 |
Use of antifungal agents for oral candidiasis: results of a national survey.
Topics: Administration, Topical; Adult; Antifungal Agents; Attitude of Health Personnel; Candidiasis, Oral; | 2010 |
Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis, Oral; Case-Control Studies; Child; | 2011 |
Childhood acute generalized exanthematous pustulosis induced by oral ketoconazole.
Topics: Acute Disease; Antifungal Agents; Candidiasis, Oral; Child; Drug Eruptions; Exanthema; Female; Human | 2010 |
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida gla | 2013 |
Azole susceptibility patterns and genetic relationship among oral Candida strains isolated in the era of highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Acti | 2002 |
Ketoconazole-induced neurologic sequelae.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis, Oral; Diagnosis, Differential; Humans; K | 2003 |
Chronic mucocutaneous candidiasis: a case report.
Topics: Antifungal Agents; Autoimmunity; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Femal | 2004 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; | 2005 |
[Oral isolates of Saccharomyces in patients with oral fungal infection and their susceptibility to antifungal drugs].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Ketoconazole; Nystatin; | 2007 |
Ketoconazole in the treatment of combined infection with dermatophytosis and candidosis.
Topics: Candidiasis, Cutaneous; Candidiasis, Oral; Child, Preschool; Humans; Ichthyosis; Ketoconazole; Male; | 1984 |
[Electron-microscopic studies during treatment of chronic generalized (granulomatous) candidiasis with ketoconazole].
Topics: Adolescent; Adult; Candidiasis, Cutaneous; Candidiasis, Oral; Female; Humans; Infant; Ketoconazole; | 1984 |
High-dose ketoconazole (HD-KNZ) in the initial treatment of leucopenic patients with fever.
Topics: Candidiasis, Oral; Child, Preschool; Fever; Humans; Ketoconazole; Leukopenia; Male | 1984 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Cryptococcosi | 1980 |
Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Hum | 1981 |
[Report on two cases of mandibular osteomyelitis caused by Candida albicans (author's transl)].
Topics: Adult; Candidiasis, Oral; Child; Female; Humans; Imidazoles; Ketoconazole; Male; Mandibular Diseases | 1982 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomyco | 1982 |
Treatment of mycoses in cancer patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Drug Therapy, Comb | 1983 |
[Treatment of severe Candida infections with ketoconazole in newborn and young infants].
Topics: Candida albicans; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Humans; Infant; Infant, Ne | 1983 |
Chronic mucocutaneous candidiasis.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Clotrimazole; Humans; Infant; Ke | 1983 |
Assessing response to therapy for mucosal candidiasis.
Topics: Candida albicans; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Female; Humans; Ketocon | 1984 |
Oral hairy leukoplakia in a HIV-negative asthmatic patient on systemic steroids.
Topics: Antifungal Agents; Asthma; Betamethasone; Candidiasis, Oral; HIV Seronegativity; Humans; Ketoconazol | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Oral candidiasis and multiple myeloma. An unusual association.
Topics: Candidiasis, Oral; Female; Humans; Immunocompromised Host; Ketoconazole; Middle Aged; Multiple Myelo | 1994 |
Fluconazole-resistant Candida in AIDS patients. Report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Drug Resistance, | 1993 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; CD4 Lymphocyte Count; C | 1996 |
Rationalizing prescribing for oral and oesophageal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs | 1996 |
Oral histoplasmosis associated with candidiasis in HIV-infected patients: a report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Female; Histopla | 1997 |
Ketoconazole resistant oral candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1997 |
Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Candida albicans; Candidias | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidias | 1997 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1997 |
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 1997 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albi | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Cand | 1998 |
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Azoles; Brazil; Candida albicans | 1998 |
Biotypes of oral Candida albicans isolated from AIDS patients and HIV-free subjects in Thailand.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis, Oral; Dose-Res | 2000 |
Oral penicilliosis in a patient with human immunodeficiency virus in northern Thailand.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Female; HIV Infections; Humans; Ketoconazole; Mouth Dis | 2000 |
Candidiasis at ICAAC.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Biological Availabil | 1995 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2001 |
Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidia | 2002 |
[Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Can | 2002 |
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Disea | 1992 |
Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.
Topics: Candida albicans; Candidiasis, Oral; DNA, Fungal; Fluconazole; HIV Infections; Humans; Ketoconazole; | 1992 |
Oral candidosis. Clinical, historical, and therapeutic features of 100 cases.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; Chlorhexidine; | 1992 |
Candida laryngotracheitis: a complication of combined steroid and antibiotic usage in croup.
Topics: Amphotericin B; Candidiasis; Candidiasis, Oral; Cefaclor; Cefuroxime; Croup; Dexamethasone; Female; | 1992 |
Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Oral; Drug Comb | 1991 |
Fluconazole resistance in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fl | 1991 |
Treatment of refractory oral candidiasis with fluconazole. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clot | 1991 |
Fluconazole resistant candida in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazol | 1991 |
Candida albicans resistance in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal | 1991 |
Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
Topics: Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; HIV Infections; HIV-1; Hu | 1990 |
A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.
Topics: Animals; Antifungal Agents; Candidiasis, Oral; Epithelium; Fluconazole; Image Processing, Computer-A | 1989 |
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Ma | 1989 |
[Stomatitis from dentures: etiopathological and therapeutic considerations].
Topics: Candidiasis, Oral; Chlorhexidine; Denture, Complete; Humans; Ketoconazole; Nystatin; Oral Hygiene; S | 1989 |
Chemotherapeutic mouthrinses in immunocompromised patients.
Topics: Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Drug Combinations; HIV Infections; Hum | 1989 |
Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis.
Topics: Candidiasis, Oral; Child, Preschool; Humans; Infant; Infant, Newborn; Ketoconazole; Nystatin; Suspen | 1989 |
Lichenoid lesions of oral mucosa associated with ketoconazole.
Topics: Adult; Candidiasis, Oral; Female; Humans; Ketoconazole; Lichen Planus; Male; Middle Aged; Mouth Dise | 1986 |
Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis.
Topics: Adrenocorticotropic Hormone; Autoimmune Diseases; Candidiasis, Oral; Child; Corticotropin-Releasing | 1986 |
Hypothyroidism after treatment with ketoconazole.
Topics: Adult; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Humans; Hypothyroidism; Ketocon | 1986 |
Resolution of candidal lesions of the dorsal rat tongue by ketoconazole.
Topics: Animals; Candidiasis, Oral; Chronic Disease; Epithelium; Female; Fibrosis; Ketoconazole; Rats; Rats, | 1988 |
The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Amphotericin B; Candida; Candidiasis, Oral; Female; Humans; | 1988 |
[A case of chronic generalized granulomatous candidiasis].
Topics: Candidiasis, Cutaneous; Candidiasis, Oral; Child; Chronic Disease; Drug Therapy, Combination; Humans | 1988 |
Use of ketoconazole (Nizoral) in fungal oral diseases.
Topics: Adult; Aged; Aged, 80 and over; Candidiasis, Oral; Female; Humans; Ketoconazole; Male; Middle Aged | 1987 |
The rational management of oral candidosis associated with dentures.
Topics: Antifungal Agents; Candidiasis, Oral; Denture Liners; Dentures; Humans; Ketoconazole; Methylmethacry | 1986 |
Treatment of otolaryngological mycoses with Nizoral.
Topics: Adolescent; Adult; Aged; Candidiasis, Oral; Female; Humans; Ketoconazole; Laryngeal Diseases; Male; | 1985 |
Candida esophagitis in two children with acute leukemia: successful therapy with ketoconazole.
Topics: Amphotericin B; Candidiasis, Cutaneous; Candidiasis, Oral; Child; Esophagitis; Female; Humans; Ketoc | 1985 |
Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Facial Dermatoses; Humans | 1985 |
[Toxoplasmosis encephalitis in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Candidiasis, Oral; Electroencephalography; Encephalit | 1985 |